Curis, Inc., a biotechnology company, is set to report its second quarter 2025 financial and operating results on August 5, 2025. The company focus...
Verastem Oncology, a biopharmaceutical company based in Boston, will report its second quarter 2025 financial results on August 7, 2025. The compan...
Verastem Oncology, a biopharmaceutical company, will host a conference call and webcast on August 7, 2025, to discuss its second quarter 2025 finan...
VF Corp.'s stock experienced a significant rise of 16.7% in premarket trading following the company's announcement of better-than-expected first-qu...
Woodward, Inc. reported third-quarter fiscal 2025 adjusted net earnings per share of $1.76, marking an 8% increase year over year and surpassing th...
Verastem Oncology, a biopharmaceutical company focused on developing treatments for RAS/MAPK pathway-driven cancers, has announced that it will rep...
UnitedHealth Group, the largest healthcare provider in the United States, reported mixed second quarter earnings, with revenues slightly exceeding ...
VF Corporation, a prominent U.S. clothing group, has reported better-than-expected financial results for the first quarter of the 2025/26 fiscal ye...
AbbVie has announced that it will release its second-quarter 2025 financial results on July 31, 2025, before the market opens. The company will hos...
Kovack Advisors Inc. has increased its holdings in Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:TSM) by 16.2% during the first quarter, as...